+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Amyotrophic Lateral Sclerosis Treatment Market Research Report by Treatment (Medication and Stem Cell Therapy), Distribution Channel, Region (Americas, Asia-Pacific, and Europe, Middle East & Africa) - Global Forecast to 2027 - Cumulative Impact of COVID-19

  • ID: 5305507
  • Report
  • April 2022
  • Region: Global
  • 219 Pages
  • 360iResearch™
UP TO OFF until Dec 31st 2022

FEATURED COMPANIES

  • AB Science SA
  • Corestem, Inc.
  • F. Hoffmann-La Roche Ltd
  • Implicit Bioscience Ltd.
  • Kringle Pharma, Inc.
  • ORPHAZYME A/S
The Global Amyotrophic Lateral Sclerosis Treatment Market size was estimated at USD 635.35 million in 2021, USD 682.69 million in 2022, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 7.62% to reach USD 987.61 million by 2027.



Market Statistics:


The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:


This research report categorizes the Amyotrophic Lateral Sclerosis Treatment to forecast the revenues and analyze the trends in each of the following sub-markets:
  • Based on Treatment, the market was studied across Medication and Stem Cell Therapy.
  • Based on Distribution Channel, the market was studied across Hospital Pharmacies and Retail Pharmacies.
  • Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:


COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:


We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.

This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Amyotrophic Lateral Sclerosis Treatment market considering the current update on the conflict and its global response.

Competitive Strategic Window:


The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:


The FPNV Positioning Matrix evaluates and categorizes the vendors in the Amyotrophic Lateral Sclerosis Treatment Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:


The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:


The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:


The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Amyotrophic Lateral Sclerosis Treatment Market, including AB Science SA, Aquestive Therapeutics Inc., Ascend Pharmaceuticals LLC, Biogen Inc., Biohaven Pharmaceutical Holding Co Ltd, Corestem, Inc., Cytokinetics, Incorporated, F. Hoffmann-La Roche AG, F. Hoffmann-La Roche Ltd, Genervon Biopharmaceuticals, LLC, GNT Pharma Co Ltd., Implicit Bioscience Ltd., Ionis Pharmaceuticals, Inc., ITF Pharma, Inc., Kringle Pharma, Inc., Orion Corporation, ORPHAZYME A/S, Otsuka Pharmaceutical Co., Ltd., Sanofi SA, Sun Pharmaceutical Industries Ltd, Synthetic Biologics, Inc., and Treeway BV.

The report provides insights on the following pointers:


1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:


1. What is the market size and forecast of the Global Amyotrophic Lateral Sclerosis Treatment Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Amyotrophic Lateral Sclerosis Treatment Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Amyotrophic Lateral Sclerosis Treatment Market?
4. What is the competitive strategic window for opportunities in the Global Amyotrophic Lateral Sclerosis Treatment Market?
5. What are the technology trends and regulatory frameworks in the Global Amyotrophic Lateral Sclerosis Treatment Market?
6. What is the market share of the leading vendors in the Global Amyotrophic Lateral Sclerosis Treatment Market?
7. What modes and strategic moves are considered suitable for entering the Global Amyotrophic Lateral Sclerosis Treatment Market?
Frequently Asked Questions about the Global Amyotrophic Lateral Sclerosis Treatment Market

What is the estimated value of the Global Amyotrophic Lateral Sclerosis Treatment Market?

The Global Amyotrophic Lateral Sclerosis Treatment Market was estimated to be valued at $635.4 Million in 2021.

What is the growth rate of the Global Amyotrophic Lateral Sclerosis Treatment Market?

The growth rate of the Global Amyotrophic Lateral Sclerosis Treatment Market is 7.6%, with an estimated value of $987.6 Million by 2027.

What is the forecasted size of the Global Amyotrophic Lateral Sclerosis Treatment Market?

The Global Amyotrophic Lateral Sclerosis Treatment Market is estimated to be worth $987.6 Million by 2027.

Who are the key companies in the Global Amyotrophic Lateral Sclerosis Treatment Market?

Key companies in the Global Amyotrophic Lateral Sclerosis Treatment Market include AB Science SA, Aquestive Therapeutics Inc., Ascend Pharmaceuticals LLC, Biogen Inc., Biohaven Pharmaceutical Holding Co Ltd, Corestem, Inc., Cytokinetics, Incorporated, F. Hoffmann and F. Hoffmann.
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • AB Science SA
  • Corestem, Inc.
  • F. Hoffmann-La Roche Ltd
  • Implicit Bioscience Ltd.
  • Kringle Pharma, Inc.
  • ORPHAZYME A/S

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Rising geriatric population worldwide
5.1.1.2. Increasing incidence rate and growing awareness about ALS
5.1.1.3. Influence of environment and lifestyle on incidence and progress of ALS
5.1.2. Restraints
5.1.2.1. High cost associated with ALS treatment
5.1.3. Opportunities
5.1.3.1. Increasing R&D in the filed
5.1.3.2. Introduction of novel medicines
5.1.4. Challenges
5.1.4.1. Less awareness in developing countries
5.2. Cumulative Impact of COVID-19
5.3. Cumulative Impact of 2022 Russia Ukraine Conflict
6. Amyotrophic Lateral Sclerosis Treatment Market, by Treatment
6.1. Introduction
6.2. Medication
6.3. Stem Cell Therapy
7. Amyotrophic Lateral Sclerosis Treatment Market, by Distribution Channel
7.1. Introduction
7.2. Hospital Pharmacies
7.3. Retail Pharmacies
8. Americas Amyotrophic Lateral Sclerosis Treatment Market
8.1. Introduction
8.2. Argentina
8.3. Brazil
8.4. Canada
8.5. Mexico
8.6. United States
9. Asia-Pacific Amyotrophic Lateral Sclerosis Treatment Market
9.1. Introduction
9.2. Australia
9.3. China
9.4. India
9.5. Indonesia
9.6. Japan
9.7. Malaysia
9.8. Philippines
9.9. Singapore
9.10. South Korea
9.11. Taiwan
9.12. Thailand
10. Europe, Middle East & Africa Amyotrophic Lateral Sclerosis Treatment Market
10.1. Introduction
10.2. France
10.3. Germany
10.4. Italy
10.5. Netherlands
10.6. Qatar
10.7. Russia
10.8. Saudi Arabia
10.9. South Africa
10.10. Spain
10.11. United Arab Emirates
10.12. United Kingdom
11. Competitive Landscape
11.1. FPNV Positioning Matrix
11.1.1. Quadrants
11.1.2. Business Strategy
11.1.3. Product Satisfaction
11.2. Market Ranking Analysis
11.3. Market Share Analysis, By Key Player
11.4. Competitive Scenario
11.4.1. Merger & Acquisition
11.4.2. Agreement, Collaboration, & Partnership
11.4.3. New Product Launch & Enhancement
11.4.4. Investment & Funding
11.4.5. Award, Recognition, & Expansion
12. Company Usability Profiles
12.1. AB Science SA
12.2. Aquestive Therapeutics Inc.
12.3. Ascend Pharmaceuticals LLC
12.4. Biogen Inc.
12.5. Biohaven Pharmaceutical Holding Co Ltd
12.6. Corestem, Inc.
12.7. Cytokinetics, Incorporated
12.8. F. Hoffmann-La Roche AG
12.9. F. Hoffmann-La Roche Ltd
12.10. Genervon Biopharmaceuticals, LLC
12.11. GNT Pharma Co Ltd.
12.12. Implicit Bioscience Ltd.
12.13. Ionis Pharmaceuticals, Inc.
12.14. ITF Pharma, Inc.
12.15. Kringle Pharma, Inc.
12.16. Orion Corporation
12.17. ORPHAZYME A/S
12.18. Otsuka Pharmaceutical Co., Ltd.
12.19. Sanofi SA
12.20. Sun Pharmaceutical Industries Ltd
12.21. Synthetic Biologics, Inc.
12.22. Treeway BV
13. Appendix
13.1. Discussion Guide
13.2. License & Pricing
List of Figures
FIGURE 1. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: DYNAMICS
FIGURE 2. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2021 VS 2027 (%)
FIGURE 3. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2021 VS 2027 (USD MILLION)
FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2027
FIGURE 5. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY MEDICATION, 2019-2027 (USD MILLION)
FIGURE 6. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 7. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY STEM CELL THERAPY, 2019-2027 (USD MILLION)
FIGURE 8. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 9. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (%)
FIGURE 10. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2021 VS 2027 (USD MILLION)
FIGURE 11. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2027
FIGURE 12. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 13. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 14. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, 2019-2027 (USD MILLION)
FIGURE 15. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2021 VS 2027 (USD MILLION)
FIGURE 16. AMERICAS AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 17. ARGENTINA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 18. BRAZIL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 19. CANADA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 20. MEXICO AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 21. UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 22. ASIA-PACIFIC AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 23. AUSTRALIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 24. CHINA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 25. INDIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 26. INDONESIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 27. JAPAN AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 28. MALAYSIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 29. PHILIPPINES AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 30. SINGAPORE AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 31. SOUTH KOREA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 32. TAIWAN AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 33. THAILAND AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 34. EUROPE, MIDDLE EAST & AFRICA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 35. FRANCE AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 36. GERMANY AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 37. ITALY AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 38. NETHERLANDS AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 39. QATAR AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 40. RUSSIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 41. SAUDI ARABIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 42. SOUTH AFRICA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 43. SPAIN AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 44. UNITED ARAB EMIRATES AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 45. UNITED KINGDOM AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
FIGURE 46. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: FPNV POSITIONING MATRIX
FIGURE 47. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: SHARE, BY KEY PLAYER, 2021
FIGURE 48. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET, BY TYPE
List of Tables
TABLE 1. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016–2020
TABLE 3. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY TREATMENT, 2019-2027 (USD MILLION)
TABLE 4. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY MEDICATION, BY REGION, 2019-2027 (USD MILLION)
TABLE 5. AMERICAS AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY MEDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 6. UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY MEDICATION, BY STATE, 2019-2027 (USD MILLION)
TABLE 7. ASIA-PACIFIC AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY MEDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 8. EUROPE, MIDDLE EAST & AFRICA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY MEDICATION, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 9. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY STEM CELL THERAPY, BY REGION, 2019-2027 (USD MILLION)
TABLE 10. AMERICAS AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY STEM CELL THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 11. UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY STEM CELL THERAPY, BY STATE, 2019-2027 (USD MILLION)
TABLE 12. ASIA-PACIFIC AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY STEM CELL THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 13. EUROPE, MIDDLE EAST & AFRICA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY STEM CELL THERAPY, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 14. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2019-2027 (USD MILLION)
TABLE 15. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 16. AMERICAS AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 17. UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 18. ASIA-PACIFIC AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 19. EUROPE, MIDDLE EAST & AFRICA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 20. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2019-2027 (USD MILLION)
TABLE 21. AMERICAS AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 22. UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY STATE, 2019-2027 (USD MILLION)
TABLE 23. ASIA-PACIFIC AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 24. EUROPE, MIDDLE EAST & AFRICA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACIES, BY COUNTRY, 2019-2027 (USD MILLION)
TABLE 25. AMERICAS AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 26. ARGENTINA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 27. BRAZIL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 28. CANADA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 29. MEXICO AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 30. UNITED STATES AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 31. ASIA-PACIFIC AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 32. AUSTRALIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 33. CHINA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 34. INDIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 35. INDONESIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 36. JAPAN AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 37. MALAYSIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 38. PHILIPPINES AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 39. SINGAPORE AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 40. SOUTH KOREA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 41. TAIWAN AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 42. THAILAND AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 43. EUROPE, MIDDLE EAST & AFRICA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 44. FRANCE AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 45. GERMANY AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 46. ITALY AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 47. NETHERLANDS AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 48. QATAR AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 49. RUSSIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 50. SAUDI ARABIA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 51. SOUTH AFRICA AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 52. SPAIN AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 53. UNITED ARAB EMIRATES AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 54. UNITED KINGDOM AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET SIZE, 2019-2027 (USD MILLION)
TABLE 55. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: SCORES
TABLE 56. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: BUSINESS STRATEGY
TABLE 57. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: PRODUCT SATISFACTION
TABLE 58. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: RANKING
TABLE 59. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: SHARE, BY KEY PLAYER, 2021
TABLE 60. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: MERGER & ACQUISITION
TABLE 61. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 62. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 63. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: INVESTMENT & FUNDING
TABLE 64. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 65. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET: LICENSE & PRICING
Note: Product cover images may vary from those shown
  • AB Science SA
  • Aquestive Therapeutics Inc.
  • Ascend Pharmaceuticals LLC
  • Biogen Inc.
  • Biohaven Pharmaceutical Holding Co Ltd
  • Corestem, Inc.
  • Cytokinetics, Incorporated
  • F. Hoffmann-La Roche AG
  • F. Hoffmann-La Roche Ltd
  • Genervon Biopharmaceuticals, LLC
  • GNT Pharma Co Ltd.
  • Implicit Bioscience Ltd.
  • Ionis Pharmaceuticals, Inc.
  • ITF Pharma, Inc.
  • Kringle Pharma, Inc.
  • Orion Corporation
  • ORPHAZYME A/S
  • Otsuka Pharmaceutical Co., Ltd.
  • Sanofi SA
  • Sun Pharmaceutical Industries Ltd
  • Synthetic Biologics, Inc.
  • Treeway BV
Note: Product cover images may vary from those shown

Loading
LOADING...